RBP2 and neoplasm: Therefore, the proportion of FABP5/CRABPII determines whether RA inhibits cell proliferation via the CRABPII/RAR signaling or facilitates tumor progression via the FABP5/PPARδ pathway (Liu et al., 2011) (Figure 5).